Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

about

Nebulized Long-Acting Beta2-Agonists: More Than Just Bridging Gaps in the Management of Symptomatic COPD Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care.

P2860

Q41441602-CFEF7ACB-6F5C-47B3-9AD3-6705F9484787 Q47710084-9121AC2D-BCB0-416D-B036-9D6A5604CB68

P2860

Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

Item

http://www.wikidata.org/entity/Q41441617

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Guiding Principles for the Use ...... PD: An Expert Panel Consensus.

@en

type

Item

label

Guiding Principles for the Use ...... PD: An Expert Panel Consensus.

@en

prefLabel

Guiding Principles for the Use ...... PD: An Expert Panel Consensus.

@en

P1476

Guiding Principles for the Use ...... PD: An Expert Panel Consensus.

@en

P2093

Antonio R Anzueto

http://www.w3.org/2001/XMLSchema#string

Donald P Tashkin

http://www.w3.org/2001/XMLSchema#string

Fernando J Martinez

http://www.w3.org/2001/XMLSchema#string

Jill A Ohar

http://www.w3.org/2001/XMLSchema#string

Robert A Wise

http://www.w3.org/2001/XMLSchema#string

Russell A Acevedo

http://www.w3.org/2001/XMLSchema#string

P2860

Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population.

Missing potential opportunities to reduce repeat COPD exacerbations.

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.

A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment.

Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review.

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values.

Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.

European Respiratory Society Guidelines on the use of nebulizers.

COPD and cognitive impairment: the role of hypoxemia and oxygen therapy

P304

7-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15326/JCOPDF.4.1.2016.0141

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicola A Hanania

P577

2016-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28848907

http://www.w3.org/2001/XMLSchema#string

P932

5560246

http://www.w3.org/2001/XMLSchema#string

Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

about

P2860

P2860

Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932